720 related articles for article (PubMed ID: 16378603)
1. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
2. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.
Zausinger S; Lumenta DB; Pruneau D; Schmid-Elsaesser R; Plesnila N; Baethmann A
Brain Res; 2002 Sep; 950(1-2):268-78. PubMed ID: 12231253
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats.
Kläsner B; Lumenta DB; Pruneau D; Zausinger S; Plesnila N
Neurochem Int; 2006 Oct; 49(5):442-7. PubMed ID: 16624448
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
5. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
[TBL] [Abstract][Full Text] [Related]
6. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
7. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.
Ding-Zhou L; Margaill I; Palmier B; Pruneau D; Plotkine M; Marchand-Verrecchia C
Br J Pharmacol; 2003 Aug; 139(8):1539-47. PubMed ID: 12922942
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
[TBL] [Abstract][Full Text] [Related]
9. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.
Esneault E; Castagne V; Moser P; Bonny C; Bernaudin M
Neuroscience; 2008 Mar; 152(2):308-20. PubMed ID: 18262367
[TBL] [Abstract][Full Text] [Related]
10. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
[TBL] [Abstract][Full Text] [Related]
11. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
12. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat.
Justicia C; Pérez-Asensio FJ; Burguete MC; Salom JB; Planas AM
J Cereb Blood Flow Metab; 2001 Sep; 21(9):1097-104. PubMed ID: 11524614
[TBL] [Abstract][Full Text] [Related]
13. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome.
Thal SC; Sporer S; Schmid-Elsaesser R; Plesnila N; Zausinger S
Crit Care Med; 2009 Jul; 37(7):2228-34. PubMed ID: 19487935
[TBL] [Abstract][Full Text] [Related]
15. Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Goyagi T; Horiguchi T; Nishikawa T; Tobe Y
Brain Res; 2010 Jul; 1343():213-7. PubMed ID: 20451506
[TBL] [Abstract][Full Text] [Related]
16. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M
J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649
[TBL] [Abstract][Full Text] [Related]
17. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
[TBL] [Abstract][Full Text] [Related]
18. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
[TBL] [Abstract][Full Text] [Related]
19. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
20. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
